The derivative short peptide P4, which is highly homologous to the extracellular domain of FGFR3c, can inhibit the proliferation, migration and invasion of tumor cells induced by FGF9, and can increase the sensitivity of gastric cancer cells to chemotherapy drugs [68]. The gene discussed is FGF9; the disease is gastric cancer.